Novavax, Inc. (NVAX)
10.46
-0.14
(-1.32%)
USD |
NASDAQ |
Oct 02, 16:00
10.44
-0.02
(-0.19%)
After-Hours: 20:00
Novavax EPS Diluted (Quarterly) : -0.3244 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3244 |
| March 31, 2026 | -0.0581 |
| December 31, 2025 | 0.1061 |
| September 30, 2025 | -1.246 |
| June 30, 2025 | 0.6159 |
| March 31, 2025 | 2.920 |
| December 31, 2024 | -0.5057 |
| September 30, 2024 | -0.7579 |
| June 30, 2024 | 0.9948 |
| March 31, 2024 | -1.055 |
| December 31, 2023 | -1.442 |
| September 30, 2023 | -1.264 |
| June 30, 2023 | 0.5822 |
| March 31, 2023 | -3.411 |
| December 31, 2022 | -2.283 |
| September 30, 2022 | -2.154 |
| June 30, 2022 | -6.533 |
| March 31, 2022 | 2.520 |
| December 31, 2021 | -11.18 |
| September 30, 2021 | -4.314 |
| June 30, 2021 | -4.754 |
| March 31, 2021 | -3.050 |
| December 31, 2020 | -2.702 |
| September 30, 2020 | -3.206 |
| June 30, 2020 | -0.2989 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.5822 |
| December 31, 2019 | -1.134 |
| September 30, 2019 | -0.7417 |
| June 30, 2019 | -1.687 |
| March 31, 2019 | -2.114 |
| December 31, 2018 | -2.575 |
| September 30, 2018 | -2.332 |
| June 30, 2018 | -2.40 |
| March 31, 2018 | -2.80 |
| December 31, 2017 | -3.20 |
| September 30, 2017 | -3.00 |
| June 30, 2017 | -3.20 |
| March 31, 2017 | -3.20 |
| December 31, 2016 | -4.20 |
| September 30, 2016 | -4.80 |
| June 30, 2016 | -5.80 |
| March 31, 2016 | -5.80 |
| December 31, 2015 | -5.80 |
| September 30, 2015 | -2.40 |
| June 30, 2015 | -1.60 |
| March 31, 2015 | -2.00 |
| December 31, 2014 | -2.60 |
| September 30, 2014 | -1.60 |
| June 30, 2014 | -1.60 |
| March 31, 2014 | -1.40 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | -0.5405 |
| Pfizer Inc. | -0.0435 |
| Agenus, Inc. | -0.0146 |
| Editas Medicine, Inc. | -0.1528 |
| Recursion Pharmaceuticals, Inc. | -0.246 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -53.39M |
| Revenue (Quarterly) | 56.70M |
| Total Expenses (Quarterly) | 110.08M |
| Enterprise Value | 1.302B |
| Gross Profit Margin (Quarterly) | 77.70% |
| Profit Margin (Quarterly) | -94.16% |
| Earnings Yield | -14.56% |
| Normalized Earnings Yield | -8.780 |